Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Nov 13, 2023 7:59pm
110 Views
Post# 35733252

LABS performance tomorrow and compare to 3 others now

LABS performance tomorrow and compare to 3 others now Lowes: downward projections 
Home Depot: downward projections
Stellantis: downward projections, offering buyout packages

Those 3 above are just the tip of iceburg as business bankruptcy filings in the U.S. are soaring.   Rising inflation at the same time as a recession?  That's a potent mix, hasn't been seen now for nearly 100 years and it took WW2 to drag them out of it but today they have difficulties funding their own government.   

So in an environment of declining revenue performance, a company that is showing strong earnings growth gains a lot more attention.

Let's see if LABS faces the same hurdles as other companies or maybe are starting to look like the goose that lays the golden eggs. 

They say during difficult economic times in the past, nobody gives up booze or their cigarettes and the same holds true for medication. 

   
<< Previous
Bullboard Posts
Next >>